Publication | Closed Access
Effects of monthly intramuscular neridronate in rheumatic patients in chronic treatment with low-dose glucocorticoids.
13
Citations
29
References
2009
Year
A twelve-month intramuscular NE treatment in rheumatic patients under GCs therapy improves lumbar and femoral BMD and mainly reduces the markers of bone resorption.
| Year | Citations | |
|---|---|---|
Page 1
Page 1